Outcomes for these patients were worse than for patients in the referent group (group 3), possibly because patients who initiate dialysis with relatively high Hb levels often do so primarily for indications that portend poor outcomes, such as uremic symptoms, severe hypertension, or volume overload; our study was not designed to address this issue. This evidence concerns the gene GSTM1 and hypertensive disorder.